Circulating Tumor Cells in BrCa: Understanding a Validated Diagnostic Tool for Precision Medicine

Circulating tumor cells as a treatment monitoring tool in metastatic breast cancerПодробнее

Clinical relevance of lipid biopsy and circulating tumor cells for precision medicineПодробнее

Mosaicism vs. Circulating Tumor Cells | Dana-Farber Cancer InstituteПодробнее

Cancer Genomics and Precision Medicine in the 21st Century - Lee HelmanПодробнее

MedGenome - BRCA (BRCA1 and BRCA2) TestingПодробнее

Tumor Molecular Testing—Making Sense of New Precision Medicine Testing Options for CancerПодробнее

Role of BRCA Mutations in BCПодробнее

Circulating Tumor Cells Clinical Utility, Challenges and Future ProspectsПодробнее

CellSearch Circulating Tumor Cell TestПодробнее

ctDNA measurement via liquid biopsy: improving cancer detection and diagnosisПодробнее

CLIA Validation of DEPArray to Overcome Limitations Associated with Current Oncological TechniquesПодробнее

Liquid Biopsy in MBC: Recognizing The Bad, The Good, and The UglyПодробнее

Precision diagnostics for blood cancers and solid tumours - Professor Anna SchuhПодробнее

ctDNA MRD detection in patients with NSCLCПодробнее

Understanding testing in breast cancerПодробнее

Blood-Based Mutation Testing: Circulating Tumor Cells and Tumor DNAПодробнее

A study of talazoparib in somatic BRCA1/2 mutant MBC identified by cfDNA or tumor tissue genotypingПодробнее

Webinar - Patient Treatment Selection & Disease Monitoring by CTC enumerationПодробнее

Biomarkers in Breast Cancer: Current Practice, Opportunities and Unmet NeedsПодробнее